Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Skelly

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology|October 28, 1998
Drug approval: future aspects of the FDAJ P Skelly
Journal of Clinical Pharmacology|October 1, 1976
Bioavailability and bioequivalenceJ P Skelly
JAMA|April 9, 1973
Biologic availability of digoxin tabletsJ P Skelly, G Knapp
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1993
In vitro/in vivo correlations in biopharmaceutics: scientific and regulatory implicationsJ P Skelly, G F Shiu
Journal of Pharmaceutical Sciences|January 1, 1992
Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creamsV P Shah, J Elkins, J P Skelly
Pharmaceutical Research|April 1, 1989
In vitro release profiles of clonidine transdermal therapeutic systems and scopolamine transdermal patchesV P Shah, N W Tymes, J P Skelly
Archives of Dermatology|November 1, 1989
'Vasoconstriction'--skin blanching--assay for glucocorticoids--a critiqueV P Shah, C C Peck, J P Skelly
Journal of Pharmaceutical Sciences|July 1, 1990
In vitro release profile of estradiol transdermal therapeutic systemsN W Tymes, V P Shah, J P Skelly
Pharmaceutical Research|May 1, 1988
Reply to "Assessment of Variance in Bioavailability Studies: comments on the article by McNamara et al." by Carl M. MetzlerJ P Skelly, V P Shah, D J Schuirmann
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1991
Stimulus selectivity and state dependence of activity in inferior temporal cortex of infant monkeysH R Rodman, J P Skelly, C G Gross
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Methods and Findings in Experimental and Clinical Pharmacology|October 28, 1998
Drug approval: future aspects of the FDAJ P Skelly
Journal of Clinical Pharmacology|October 1, 1976
Bioavailability and bioequivalenceJ P Skelly
JAMA|April 9, 1973
Biologic availability of digoxin tabletsJ P Skelly, G Knapp
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1993
In vitro/in vivo correlations in biopharmaceutics: scientific and regulatory implicationsJ P Skelly, G F Shiu
Journal of Pharmaceutical Sciences|January 1, 1992
Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creamsV P Shah, J Elkins, J P Skelly
Pharmaceutical Research|April 1, 1989
In vitro release profiles of clonidine transdermal therapeutic systems and scopolamine transdermal patchesV P Shah, N W Tymes, J P Skelly
Archives of Dermatology|November 1, 1989
'Vasoconstriction'--skin blanching--assay for glucocorticoids--a critiqueV P Shah, C C Peck, J P Skelly
Journal of Pharmaceutical Sciences|July 1, 1990
In vitro release profile of estradiol transdermal therapeutic systemsN W Tymes, V P Shah, J P Skelly
Pharmaceutical Research|May 1, 1988
Reply to "Assessment of Variance in Bioavailability Studies: comments on the article by McNamara et al." by Carl M. MetzlerJ P Skelly, V P Shah, D J Schuirmann
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1991
Stimulus selectivity and state dependence of activity in inferior temporal cortex of infant monkeysH R Rodman, J P Skelly, C G Gross
Pageof 5